Tags
AM2PAT Inc., bacteria, Balakrishnan Rajendran, blindness, BrahMos, BrahMos missiles, CA, caste system, Chennai, CO, contaminated eye drops, CT, Death, Delsam Pharma Artificial Tears, drug resistant bacteria, drug resistant infection, Dushyant Mahendrabhai Patel, exports from India, eye drops, EzriCare Artificial Tears, FDA most wanted, FL, Global Pharma Healthcare, IL, India, India caste system, India exporting contaminated pharma products, Ishvi Khare, Juma Venkatesh, Kamma caste, Kayastha, Manickam Kamalakannan, microbial testing, murder, NC, NJ, NM, NV, NY, PA, pan-Indian elite, pharmaceutical imports, preservatives, quality control, Russia, Russian allies, scribal caste, SD, tamper-proof packaging, TX, upper caste, upper caste Hindus, US FDA, UT, WA, WI
The government of India is making missiles with Russia in a joint venture (Brahmos) and a company there has exported eye drops, contaminated with a rare drug resistant bacteria, which have killed and blinded Americans. This dangerous bacteria did not previously exist in the United States until India exported it in these eye drops. How much more will India be allowed to get by with? These eyedrops came from Chennai, which is where the CEO of Google and Kamala Harris’ family are from.
“The outbreak strain, carbapenem-resistant Pseudomonas aeruginosa with Verona integron-mediated metallo-β-lactamase and Guiana extended-spectrum-β-lactamase (VIM-GES-CRPA), had never been reported in the United States prior to this outbreak. The outbreak is associated with multiple types of infections, including eye infections.”
Why didn’t the US FDA check these things ahead of time?
US “FDA recommended this recall due to the company’s current good manufacturing practice (CGMP) violations, including lack of appropriate microbial testing, formulation issues (the company manufactures and distributes ophthalmic drugs in multi-use bottles, without an adequate preservative), and lack of proper controls concerning tamper-evident packaging.”
What will it take for Americans to wake up to the danger posed by India? An attack on the USA with one of India’s Brahmos missiles? Remember that Kamala Harris’ uncle bragged about deceiving the USA with nuclear missile tests. He may have been involved in this deception: https://miningawareness.wordpress.com/2020/09/26/kamala-harris-uncle-brags-about-india-deceiving-the-cia-with-nuclear-weapons-tests-kamala-deceives-biden-about-her-uncles-advisory-role-to-indias-ministry-of-defence/
Much more recently, India has bragged that it won’t stop its defense partnership with Russia: https://miningawareness.wordpress.com/2023/03/19/head-of-india-russia-missile-joint-venture-brahmos-brags-west-wont-be-able-to-halt-india-russia-defense-partnership/
Remember this? https://miningawareness.wordpress.com/2020/08/21/kamala-harris-uncle-called-russia-steadfast-friends-after-russia-annexed-crimea/
Why does India always get by with murder, whether metaphorical or literal? Apparently because the US government, media, and especially the tech sector, are infested with de facto foreign agents. They have also taken over most of the USA’s hotel-motel sector, which is why most US hotel-motels are too filthy to stay in. It also allows them to know who is having affairs with who, and exercise control accordingly. This is especially true in small towns with one motel run by immigrants from India.
Unlike in the UK, the vast majority of migrants from India in the USA are upper caste Hindus.
Affirmative action in India predates that of the USA. Not wanting to share with the under castes, the upper caste Hindus were allowed to come to the USA and get affirmative action, which was meant for African Americans and American women! This is like white South Africans claiming affirmative action in the USA, because they are Africans, which probably has happened,too,
Since the US opened the flood gates to India, less than 60 years ago, they have apparently infested institutions throughout the United States through mass migration, family joining, and the US govt giving them priority in hiring and contracting, as a “minority”. Soon more populous than China, they aren’t a “minority”. Both Kamala Harris’ family and the CEO of Google, Sundar Pichai, are from Chennai, the source of the contaminated eye drops. In fact, Kamala’s family and Sundar Pichai lived very close to each other; and are both Hindu Brahmin families, who probably went to the same temple.
The US let Dushyant Mahendrabhai Patel, who was on the FDA most wanted list, get by with murder because they couldn’t find him for 11 years. In stark contrast, the US government has shown no qualms about prosecuting Americans decades after they have murdered people: “Dushyant Mahendrabhai Patel (born 1958) is an Indian-American businessman who served as president of the company called AM2PAT Inc. based in Raleigh, North Carolina.[1] Under his presidency, the company sold untested syringes of heparin that were tied to the deaths of at least 5 people and the hospitalizations of hundreds.[2] In 2009, Patel was listed as one of the most wanted fugitives sought by the United States Food and Drug Administration’s Office of Criminal Investigations (OCI).[3] The federal charges against him were dropped in 2021, by which time he had eluded capture for 12 years.[4] https://en.wikipedia.org/wiki/Dushyant_Mahendrabhai_Patel
Related: https://en.wikipedia.org/wiki/2008_Chinese_heparin_adulteration
The New Indian Express assured people there that the eye drops “are not sold in India”: “Global Pharma Healthcare is recalling entire lots of eye drops linked to vision loss in the US, according to the US Food and Drug Administration. These eye drops are not sold in India”. https://web.archive.org/web/20230203172223/https://www.newindianexpress.com/world/2023/feb/03/fda-restrict-imports-of-india-made-pharma-company-linked-to-vision-loss-in-us-2544072.html
The most recently added director of Global Pharma is “ISHVI KHARE, 1 Apr 2022” https://opencorporates.com/companies/in/U51102TN1986PTC013099
Khare is a kayastha surname, who are a scribal caste described as “urban-oriented”, “upper caste” and part of the “well-educated” pan-Indian elite” https://en.wikipedia.org/wiki/Kayastha https://en.wikipedia.org/wiki/Khare
Other director-officers are “BALAKRISHNAN RAJENDRAN, director, 15 Dec 2011-; JUMA VENKATESH, director, 26 Jul 2006-; MANICKAM KAMALAKANNAN, director, 6 Apr 2012-“
https://opencorporates.com/companies/in/U51102TN1986PTC013099
Venkatesh is apparently from the Kamma caste: https://opencorporates.com/companies/in/U51102TN1986PTC013099
Manickam is apparently upper caste because someone by that surname was arrested for threatening a member of under castes, who entered the temple:
“DMK leader Manickam who threatened to kill a SC youth and used casteist slurs against him after he entered a Hindu temple in TN’s Salem has been arrested.” https://twitter.com/SurajKrBauddh/status/1620314485058830341
So, Americans are being treated in a similar manner to how these upper caste Indians treat their own undercastes.
“Outbreak of Extensively Drug-resistant Pseudomonas aeruginosa Associated with Artificial Tears: Summary of Recent Updates
Updates as of March 14, 2023
CDC is collaborating with the Food and Drug Administration (FDA) and state and local health departments to investigate a multistate outbreak of an extensively drug-resistant strain of Pseudomonas aeruginosa. The outbreak strain, carbapenem-resistant Pseudomonas aeruginosa with Verona integron-mediated metallo-β-lactamase and Guiana extended-spectrum-β-lactamase (VIM-GES-CRPA), had never been reported in the United States prior to this outbreak. The outbreak is associated with multiple types of infections, including eye infections. The investigation to date has identified artificial tears as a common exposure for many patients.
Current Update
As of March 14, 2023, CDC, in partnership with state and local health departments, identified 68 patients in 16 states (CA, CO, CT, FL, IL, NC, NJ, NM, NY, NV, PA, SD, TX, UT, WA, WI) with VIM-GES-CRPA, a rare strain of extensively drug-resistant P. aeruginosa. Thirty-seven patients were linked to four healthcare facility clusters. One person has died and there have been 8 reports of vision loss and 4 reports of enucleation (surgical removal of eyeball). Dates of specimen collection were from May 2022 to February 2023. Isolates have been identified from clinical cultures of sputum or bronchial wash (15), cornea (17), urine (10), other nonsterile sources (4), and blood (2), and from rectal swabs (26) collected for surveillance; some patients had specimens collected from more than one anatomic site.
Most patients reported using artificial tears. Patients reported over 10 different brands of artificial tears and some patients used multiple brands. EzriCare Artificial Tears, a preservative-free, over-the-counter product packaged in multidose bottles, was the brand most commonly reported. This was the only common artificial tears product identified across the four healthcare facility clusters. Laboratory testing by CDC identified the presence of VIM-GES-CRPA in opened EzriCare bottles from multiple lots; these bottles were collected from patients with and without eye infections and from two states. VIM-GES-CRPA recovered from opened products match the outbreak strain. Testing of unopened bottles of EzriCare Artificial Tears is ongoing to assist in evaluating for whether contamination may have occurred during manufacturing. Patients and healthcare providers should immediately stop the use of EzriCare Artificial Tears pending additional information and guidance from CDC and FDA.
FDA encourages health care professionals and patients to report adverse events or quality problems with any medicine to FDA’s MedWatch Adverse Event Reporting program.
Consumers may also report adverse reactions by contacting FDA’s Consumer Complaint Coordinators” See more here: https://www.cdc.gov/hai/outbreaks/CRPA-artificial-tears.html
“[2/2/2023] FDA is warning consumers and health care practitioners not to purchase and to immediately stop using EzriCare Artificial Tears or Delsam Pharma’s Artificial Tears due to potential bacterial contamination. Using contaminated artificial tears increases risk of eye infections that could result in blindness or death. Patients who have signs or symptoms of an eye infection should talk to their health care provider or seek medical care immediately.
These are over-the-counter products, manufactured by Global Pharma Healthcare Private Limited, intended to be sterile.
Global Pharma initiated a voluntary recall at the consumer level of all unexpired lots of EzriCare Artificial Tears and Delsam Pharma’s Artificial Tears. FDA recommended this recall due to the company’s current good manufacturing practice (CGMP) violations, including lack of appropriate microbial testing, formulation issues (the company manufactures and distributes ophthalmic drugs in multi-use bottles, without an adequate preservative), and lack of proper controls concerning tamper-evident packaging.
FDA is collaborating with the Centers for Disease Control and Prevention (CDC) and state and local health departments to investigate a multistate outbreak involving a rare, extensively drug-resistant strain of Pseudomonas aeruginosa bacteria. As of January 31, 2023, CDC identified 55 patients in 12 states with infections that have been linked by epidemiologic and laboratory evidence to use of EzriCare Artificial Tears. Associated adverse events include hospitalization, one death with bloodstream infection, and permanent vision loss from eye infections. CDC issued an alert recommending consumers stop using EzriCare Artificial Tears pending additional guidance from CDC and FDA.
FDA also placed Global Pharma Healthcare Private Limited on import alert for providing an inadequate response to a records request and for not complying with CGMP requirements. The import alert prevents these products from entering the United States. FDA encourages health care professionals and patients to report adverse events or quality problems with any medicine to FDA’s MedWatch Adverse Event Reporting program”:
See more here: https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-purchase-or-use-ezricare-artificial-tears-due-potential-contamination
This man from India’s company had unhygienic practices which killed five people and led to the hospitalization of hundreds but after he was on the run for 11 years the US dropped charges! How can this be?
This was allowed in the USA. Do facilities in India look better? “Finally, after reports of harm in late 2007, FDA inspectors combed the plant, called AM2PAT. They discovered a “gummy brown” substance on the syringe-filling machine and brown water flowing from taps, among other problems. The plant was closed in January 2008.”https://www.propublica.org/article/tainted-syringes-slipped-past-fda-watch-607
“Dushyant Mahendrabhai PATEL
Summary of OCI Investigation:
From 2003 through October 2007, PATEL served as President of a company based in Raleigh, North Carolina called AM2PAT Inc. that sold medical devices, specifically syringes pre-filled with Heparin, a commonly used anticoagulant. PATEL, acting in the capacity of President of AM2PAT Inc., falsely certified to the U.S. Food & Drug Administration that medical devices sold by AM2PAT Inc. were manufactured according to approved methods, when in fact, PATEL and others provided false information regarding the manufacturing and testing process. Specifically, they falsely certified that sterility testing was completed indicating the products sold were safe and effective. In fact, in order to maximize profits, PATEL and others shipped these medical devices into interstate commerce for public use before any sterility testing was done, which resulted in un-safe products being used by medical institutions on patients. These products ultimately caused directly or indirectly at least five deaths and the hospitalization of hundreds of other patients because the products triggered an outbreak of bacterial infections.
Also Known As:
Dushyant Mahendra PATEL
Date and Place of Birth:
7 July 1958 — Thana, India”https://web.archive.org/web/20190612180457/https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/office-criminal-investigations-most-wanted-fugitives/office-criminal-investigations-oci-most-wanted-fugitives
https://en.wikipedia.org/wiki/Dushyant_Mahendrabhai_Patel
https://en.wikipedia.org/wiki/Dushyant_Mahendrabhai_Patel
“Global Pharma Healthcare Private Limited
Date Published : 01/03/2023
A – 9 Sidco Pharmaceutical Complex , Thiruporur , Chennai, Tamil Nadu INDIA
55 – – – — Pharm Necess & Ctnr For Drug/Bio
Date Published: 01/03/2023
Notes: All Drug and Drug Products
56 – – – — Antibiotics (Human/Animal)
Date Published: 01/03/2023
Notes: All Drug and Drug Products
58 – – – — Human and Animal Therapeutic Biologic and Biosimilar Drugs
Date Published: 01/03/2023
Notes: All Drug and Drug Products
60 – – – — Human and Animal Drugs
Date Published: 01/03/2023
Notes: All Drug and Drug Products
61 – – – — Human and Animal Drugs
Date Published: 01/03/2023
Notes: All Drug and Drug Products
62 – – – — Human and Animal Drugs
Date Published: 01/03/2023
Notes: All Drug and Drug Products
63 – – – — Human and Animal Drugs
Date Published: 01/03/2023
Notes: All Drug and Drug Products
64 – – – — Human and Animal Drugs
Date Published: 01/03/2023
Notes: All Drug and Drug Products
65 – – – — Human and Animal Drugs
Date Published: 01/03/2023
Notes: All Drug and Drug Products
66 – – – — Human and Animal Drugs
Date Published: 01/03/2023
Notes: All Drug and Drug Products
https://www.accessdata.fda.gov/cms_ia/importalert_189.html
Mining Awareness + 